Chabiotech Co.,Ltd. (KOSDAQ:085660)
7,810.00
-230.00 (-2.86%)
Sep 22, 2026, 3:30 PM KST
Chabiotech Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,311,354 | 1,268,254 | 1,045,049 | 953,951 | 844,583 | 727,476 |
Revenue Growth | 13.93% | 21.36% | 9.55% | 12.95% | 16.10% | 9.44% |
Gross Profit Gross Profit Growth | 362,131 | 354,197 | 269,824 | 271,016 | 201,025 | 213,498 |
Operating Income Operating Income Growth | -82,554 | -57,147 | -59,975 | -9,425 | -53,669 | 6,397 |
Net Income Net Income Growth | 14,272 | -109,876 | -4,764 | -8,431 | -47,543 | -13,968 |
Earnings Per Share EPS Growth | 11.70 | -1649.00 | -321.50 | -149.80 | -845.00 | -256.29 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Internal Sales Internal Sales Growth | -11,607 | -10,031 | -8,123 | -10,240 | -8,482 | -9,073 |
Health Care Health Care Growth | 1,220,566 | 1,196,749 | 1,000,318 | 906,261 | 808,246 | 693,469 |
Other Other Growth | 90,337 | 67,794 | 48,464 | 46,020 | 41,682 | 37,954 |
Finance Finance Growth | 12,059 | 13,741 | 4,389 | 11,910 | 3,138 | 5,126 |
Total Total Growth | 1,311,354 | 1,268,254 | 1,045,049 | 953,951 | 844,583 | 727,476 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 364,236 | 339,225 | 353,501 | 221,789 | 250,627 | 343,527 |
Total Debt Total Debt Growth | 815,347 | 905,433 | 825,938 | 449,635 | 400,860 | 341,190 |
Net Cash (Debt) Net Cash Growth | -451,110 | -566,207 | -472,437 | -227,846 | -150,233 | 2,337 |
Net Cash Growth | - | - | - | - | - | -93.49% |
Net Cash Per Share Net Cash Per Share Growth | -5318.15 | -8435.60 | -7941.63 | -3992.36 | -2670.02 | 42.88 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -100,516 | -72,104 | -48,244 | 13,018 | -19,399 | 26,248 |
Capital Expenditures CapEx Growth | -182,603 | -146,985 | -93,947 | -70,365 | -120,355 | -112,598 |
Free Cash Flow Free Cash Flow Growth | -283,120 | -219,089 | -142,191 | -57,346 | -139,754 | -86,350 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.62% | 27.93% | 25.82% | 28.41% | 23.80% | 29.35% |
Operating Margin | -6.30% | -4.51% | -5.74% | -0.99% | -6.35% | 0.88% |
Pretax Margin | 0.28% | -11.30% | -0.28% | 0.33% | -8.44% | -1.38% |
Profit Margin | 1.09% | -8.66% | -0.46% | -0.88% | -5.63% | -1.92% |
FCF Margin | -21.59% | -17.27% | -13.61% | -6.01% | -16.55% | -11.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 44.03 | 44.03 | 44.03 | 44.03 | 44.03 |
PS Ratio | 0.57 | 0.88 | 0.61 | 1.16 | 0.87 | 1.54 |